Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study. [electronic resource]
Producer: 20190708Description: 118-121 p. digitalISSN:- 1873-6815
- Aged
- Aged, 80 and over
- Alzheimer Disease -- drug therapy
- Apolipoproteins E -- genetics
- Brain -- physiopathology
- Brain Mapping
- Cerebrovascular Circulation -- drug effects
- Cognition
- Diet, Ketogenic
- Double-Blind Method
- Female
- Humans
- Ketone Bodies -- metabolism
- Male
- Middle Aged
- Pilot Projects
- Positron-Emission Tomography
- Triglycerides -- pharmacology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.